Introduction
Single-photon emission computer tomography (SPECT) has been widely utilized clinically for imaging cancer metastases 1 and preclinically for screening the biodistribution of targeted substances. 2 Gamma-emitting isotopes such as 99m Tc, 111 In, 123 I, 125 I and 131 I are most widely used, resulting in planar or three-dimensional (3D) images. In gene therapy imaging, particle biodistribution and transductional imaging studies have shown potential in the development of improved gene therapy vectors. 3 Although the results from the transgene expression pattern are vital for the success of gene therapy, biodistribution of the viral particles needs to be carefully studied as well. For example, viral particle accumulation in organs such as liver could cause immunoresponse even if the virus was unable to express any transgene. Therefore, real-time imaging of the viral particle distribution will generate important safety information and results about the kinetics of administration and result in new target tissues.
For particle biodistribution imaging, non-invasive imaging has several benefits when compared to the traditional immunological and histological methods. The ability to image the signal real-time together with accurate anatomical reference is crucial for understanding the kinetics of viral administration and optimizing the viral dose to target tissue. Previously, SPECT has been utilized in gene therapy by imaging the particle biodistribution of adenovirus knob domain, 4 and by imaging of indium-labelled herpes simplex viruses. 5, 6 The interest of baculoviruses as gene therapy vectors has increased tremendously during the last decade, reflecting increased demand to develop alternative gene therapy vectors. The inherent safety of baculoviruses deriving from insect host origin together with easy production and high transgene capacity have made baculoviruses a potential alternative for various in vivo approaches. [7] [8] [9] Although numerous cell lines have been described to be susceptible to baculovirus transduction, [10] [11] [12] [13] there are yet only a few studies dealing with baculovirus biodistribution in vivo. 7, 14, 15 We have previously reported the construction of a novel avidin-displaying baculovirus (Baavi) with enhanced transduction efficiency in vitro 16 and showed it to be suitable for viral particle biodistribution imaging using avidin-biotin labelling and magnetic resonance imaging (MRI). 17 Here, we present biodistribution studies using Baavi in Wistar rats, the virus coated with 99m Tc-labelled polylys-ser-DTPA-biotin peptide and imaged with a microSPECT/computed tomography (CT) device. Intrafemoral (i.f.), intramuscular (i.m.), intracerebroventricular (i.c.v.) and intraperitoneal (i.p.) administration routes were applied to image short-term biodistribution of the viral vector in vivo, together with measurement of the distributed dose from the dissected organs. We were able to detect signs of lymphatic trafficking with i.m., i.p. and i.f. administration and could detect concentration of the signal to the nasal area after i.f. administration. The i.m. and i.f. administrations resulted in kidney transduction, whereas i.p. administration also resulted in transduction of spleen and lungs. Altogether, the study suggested that kidney might be a feasible target for baculovirus transduction by using i.p. administration.
Results

Labelling quality and imaging
With all chelate labellings (Figure 1 ), the peptide-bound fractions of 99m Tc were higher than 90% as demonstrated by paper chromatography.
Intrafemoral administration
Intrafemoral administration was performed to analyse the systemic biodistribution of labelled baculovirus. The SPECT imaging during 5-60 min time was performed in two sections, head and abdomen, and region of interest (ROI) count averages were calculated. After the injection of labelled virus (Figure 2a) , the activity in the bladder was seen to increase from 0.62 to 3.68 count s À1 MBq
À1
(values for 5 and 60 min) and in kidneys from 4.82 to 5.03 count s À1 MBq
. Also in the abdomen, the systemically injected radiolabelled chelate alone (Figure 2b ) resulted in bladder from 0.81 to 1.22 and in kidneys from 1.15 to 1.34 count s À1 MBq
. Animals receiving Baavi also showed activity in lungs, liver and spleen ( Figure 2a) .
In head section, the planar images from animal head and neck showed increased radioactivity first in the lymphatic nodes of the neck with 0.002 count s À1 MBq À1 during 15-25 min and then in the nasal area with 0.002 count s À1 MBq À1 during 30-50 min (Figure 2c ), whereas the chelate control had decreasing activity in the circulation without signs of accumulation of the signal (Figure 2d ). The 3D SPECT and superimposed SPECTCT images confirmed the positivity in the nasal area and lymphatic nodes (Figure 2e ).
After the systemic injection, baculoviral transgene expression could be detected in liver and kidneys (Table 1) .
Intraperitoneal administration
After i.p. injection of baculovirus, the planar images showed instant spreading of the injected dose across the abdominal cavity, confirming successful injection. During 5-60 min imaging time, the ROI count averages in abdominal organs were as follows: in kidneys from 0.49 to 0. 32 (Figure 3a and b) . Transduction in the kidney was extensive in the capsule and outer cortex area, within the tubular epithelial cells of the kidney. The marker gene expression could also be confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and anti-b-galactosidase protein immunostaining (Figure 3c and d) . We also observed that during the 60 min time, the mediastinal lymphatic nodes could also be occasionally imaged (Figure 4a ).
Intramuscular administration
Intramuscular injections were administered to analyse the behaviour of baculovirus in a more localized environment. The injections were carefully placed to avoid major blood-vessels, which could affect the biodistribution. The virus spread to femoral area was seen by appearing spot areas with ROI count averages of 10.39 count s À1 MBq À1 (Figure 4b ) very quickly after the injections, whereas the radiolabelled chelate-injected controls showed the activity remaining only in the injection site (Figure 4c ). There were very little changes in the activity of the areas during the observation time.
Interestingly, we could occasionally detect activity in the lymphatic nodes of head and neck in virus-injected animals with late imaging time points. The baculoviral transgene expression could be detected only in the kidney (Table 1) .
Intracerebroventricular administration
Injections to cerebral lateral ventricle were administered to analyse the drainage of the injected dose from the brain. As compared to the animals injected with chelate control, the activity in brains after injection of labelled baculovirus was constantly lower after perfusion and dissection (Table 1) , indicating faster removal of the labelled virus as compared to the radiochelate control. Additionally, the planar SPECT imaging showed ROI count average of 0.56 count s À1 MBq À1 in kidneys (Figure 4d ), seen first 65 min after the i.c.v. injections of labelled virus. Because of the small injected volume of the baculovirus, no transgene expression was studied.
Discussion
Owing to their safety and ease of production, baculoviruses have become attractive gene delivery vectors. Although the specific interactions between baculovirus surface proteins and target cellular receptors are not exactly known, there is a hypothesis of virus binding via heparate sulphate residues 18 and phospholipids 19 supported by a large number of baculovirus-susceptible cell lines in vitro. 13 When considering the possible clinical use of baculoviruses, the transductional kinetics and suitable administration methods of baculoviruses in vivo have to be evaluated. Previously, it has been reported that baculovirus transduction in vivo is inhibited by the blood complement system, 20 and several approaches have been published to circumvent this problem. 15, 21, 22 As an alternative approach, baculoviruses have been successfully used in vivo in immunopriviledged areas, such as the eye 8 or central nervous system (CNS). 7, 23, 24 However, large viral tropism together with reports on systemic escape 7 and transportation via axons 25 raise a question for examining the baculovirus kinetics in vivo after different administration methods. Biodistribution studies SPECT/CT imaging of baculovirus biodistribution in rat JK Räty et al based on the transgene expression pattern of the virus do not provide accurate information about the viral particle distribution kinetics after administration. Therefore, tracking of viral particles can provide important information about baculovirus systemic kinetics and safety of the administration. In this study, we compared polylys-serine-DTPA chelate 99m Tc-labelled baculovirus virion biodistribution by using i.f., i.m., i.c.v. and i.p. administration routes. By using a combined microSPECT/CT device, the particle biodistribution can be monitored in real time with SPECT and anatomical referencing.
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To evaluate the viral behaviour with wide organ access via the circulation, we performed systemic injection via v. femoralis (i.f., Figure 2 ). SPECT planar imaging of viral dose showed increasing activity in the lungs, liver, spleen and kidneys, whereas imaging of the radiolabelled chelate or 99m Tc alone (data not shown) resulted in brightening of kidneys, ureters and bladder as the urinary export of water-soluble substances progressed. It has been shown that the reticulo-endothelial system of liver plays an important role in the active disposal of administered viral particles. 26 In agreement with this, some transgene expression could be detected in the liver, likely in macrophages (data not shown). However, contrary to i.f. injection of the wild-type virus with the labelled chelate, Baavi resulted in moderate b-galactosidase expression in kidneys and liver (Table 1) . In previous studies, baculoviral gene expression could be detected in the liver, spleen and kidney after systemic tail-vein administration to complement-deficient mice. 14 Another study showed green fluorescent protein (GFP) expression after i.v. administration of baculovirus in liver, spleen, lung, heart, kidney and brains of BALB/c mice, 22 although no GFP or luciferase expression was seen in vesicular stomatitis virus G-protein (VSV-G) displaying baculovirus in the same strain of mice. 15 The latter is interesting, as the VSV-G display has been reported to protect from the complement system of blood. 27 The contradiction between these two results, namely transgene expression in multiple organs or no expression, could suggest that factors other than the complement had an effect on the in vivo transduction of baculovirus.
Interestingly, in our study the signal after viral i.f. administration was seen to concentrate on the nasal area of the rat. Previously, feline immunodeficiency viruses pseudotyped with baculovirus Gp64 glycoprotein were shown to transduce olfactory and respiratory epithelial cells 28 and wild-type baculovirus was shown to induce a strong innate immune response after intranasal administration, 29 suggesting that baculovirus might have tropism for cells in the nasal area.
When examining the radioactivity of dissected organs vs transgene expression (Table 1) , the correlation was not always complete. Because baculovirus transduction contains a step for capsid transport to the nucleus, any hindrance in that step is likely to prevent marker gene expression, even while the viral tropism would result in accumulation in tissues and furthermore in a positive signal in SPECT imaging. We speculate that depending on the method of administration, the detection level for transduction might be affected by the complement and/or the poor nuclear transport within the cells, as suggested by an earlier study. 30 Another administration method, i.p. injection, has been used for the treatment of ovarian cancer, in an attempt to overcome the limitations of intratumoral injections for improved access to the peritoneal cavity. 31 The i.p. injection of labelled Baavi resulted in significantly increased radioactivity in spleen and kidney detected by a gammacounter and detailed SPECT analysis. b-galactosidase stainings of spleen resulted in moderate expression of the LacZ transgene and strong and extensive expression in kidney (Figure 3) . The results were confirmed by RT-PCR and immunohistochemistry. As spleen is known to have high concentrations of iron, we also performed control stainings without the X-gal substrate to exclude the possible reaction of ferri-and ferrocyanide to form a blue SPECT/CT imaging of baculovirus biodistribution in rat JK Räty et al precipitate with free ferric iron (Prussian blue reaction). The control stainings were negative (data not shown), confirming the results.
According to the literature, baculoviruses have previously been shown to efficiently transduce various mammalian kidney cell lines in vitro; 32, 33 these results are also in agreement with previous results of kidney transduction in vivo.
14 It might be possible that avidin display has enhanced the baculovirus transduction mechanism, as suggested by our previous study, 16 to result in efficient transduction after i.p. and i.f. administration. After i.p. administration, some b-galactosidase expression could also be seen in lungs and brain and SPECT/CT imaging of baculovirus biodistribution in rat JK Räty et al radioactivity was occasionally detected in mediastinal nodes during the SPECT imaging after i.p. administration ( Figure 4a ). As the peritoneal fluid enters from peritoneum to lymphatic lacunae and continues onwards via parasternal lymphatics to superior mediastinal nodes, 34, 35 our results suggest that baculovirus may enter the lymphatic circulation from the peritoneal lymphatic drainage and is able to spread systemically via lymphatics, in agreement with the results from systemic escape 7 and distribution of avidin/biotin liposomes via lymphatic system. 36 Transgene expression could also be detected in the kidney cells ( Table 1 ), indicating that injected dose might escape to systemic circulation.
Intramuscular injections have previously been successfully used in transduction of mouse skeletal muscle with VSV-G displaying baculovirus, 37 and in vaccination studies, 29, 38 providing data that mouse muscle might be an attractive target. Yet, in the present study, rat muscle did not result in detectable transduction, as opposed to rabbit muscle, which was transduced with VSV-GED displaying baculovirus. 39 It is likely that difference in the species and viral pseudotype explains this variation. However, similar to i.p. results, after i.m. Baavi injection we could detect the femoral lymphatic nodes being imaged (Figure 4b ), supporting the observation of viral traffic via the lymphatic system.
When considering the transduction of cerebrospinal fluid producing choroid plexus cells, i.c.v. injection provides access with a limited invasion. Although CNS has been a popular target for baculovirus-mediated gene delivery, the viral kinetics after i.c.v. injection still remain obscure, providing concern about systemic escape. In this study, after i.c.v. injection of labelled Baavi or chelate alone, the remaining radioactivity in rat brain with Baavi was lower as compared to the chelate control, supporting further the theory of systemic escape. We could detect a signal in the kidneys 65 min after the i.c.v. injection (Figure 4d ), indicating escape of the virus from the cerebrospinal fluid circulation, not detected with the control. As compared to the MRI, 17 the lower anatomical resolution of SPECT with the small injected volume and consequent low radioactivity (5-8 MBq) prevents further pinpointing of the viral biodistribution in the brain. Interestingly, there is a report on baculoviral traffic via axons, 25 thus contributing to viral biodistribution with a previously unexpected manner, similarly to observation of systemic escape. 7 When comparing different administration routes with each other, the administration via peritoneum might result in effective gene delivery to the organs in and around the abdominal cavity without strongly activating the complement system leading to virus degradation. Earlier it has been reported that the peritoneal cavity may have a dimished level of complement, 40 thus protecting the baculovirus from complement-related inactivation and favouring later transduction. This observation could also explain the stronger transduction after i.p. administration as compared to i.f. administration. We speculate that transduction from the renal capsule side could be more efficient or that during trafficking via the lymphatic system, the avidin-displaying baculovirus may become associated with lymphatic proteins/lipids, providing resistance towards complement when released back to blood circulation. It has been recently shown that peritoneal administration can be used to reduce the side effects while reaching the therapeutics window with a smaller dose of chemotherapeutic agents. 41 In conclusion, the results of this study suggest that baculoviral administration via the peritoneum might offer a new way to target kidney and treat kidney-related diseases. 42, 43 This study also suggests that baculovirus spreads via the lymphatic system and influences baculovirus transduction and biodistribution. Further studies are required to confirm traffic via the lymphatic system and the effects on gene therapy treatment and safety.
Materials and methods
Synthesis of the biotinylated multi-ser/lys molecule Biotinylated multi-lysine molecule Biot-PEG-SKSKSKSKSKSKSKSKSKSK(Biot)-G (Figure 1 ) was synthesized using an Apex 396 DC multiple peptide synthesizer (Advanced ChemTech, Louisville, KY, USA) with Fmoc strategy; Fmoc-Gly-Wang (Novabiochem, Läufelfingen, Switzerland) was used as solid phase. The side-chain protecting groups used in synthesis were t-butyloxycarbonyl (Boc) for Lys [1] [2] [3] [4] [5] [6] [7] [8] [9] or (Mtt) for Lys 10 and tert-butyl (tBu) for Ser. Polyethylene glycol was added to the molecule as Fmoc-protected acid (2-2-Fmoc-aminoethoxylethoxy acetic acid). After synthesis, Mtt groups were removed with 1% TFA in dichloromethane (DCM) in order to release the primary amine of Lys 10 on resin. Biotin was coupled to an a-amino group and a free side chain via valeriana acid TBTU/DIPEA as the coupling reagent. After cleavage, molecule was purified by HPLC (Shimadzu, Kioto, Japan) with a C 18 reverse phase column (xTERRA, Waters, Milford, MA, USA) and acetonitrile (ACN) as eluent (0.1% TFA in H 2 O/0-60% ACN gradient for 60 min), verified with ABI QStar LC-ESI mass spectrometer (Applied Biosystems, Foster City, CA, USA) and the purity was determined by analytical HPLC with a 240 Â 1.4 mm C 18 column (xTERRA, Waters, Milford, MA, USA) and 0-60% ACN for 30 min. Lyophilized molecule was dissolved in water before diethylenetriaminepentaacetic acid (DTPA) labelling.
DTPA labelling
The side chains of the biotinylated multi-lys molecule were labelled with ITC-DTPA (Macrocyclics, Dallas, TX, USA) by using a molar ratio of 1:20. 10 mg of ITC-DTPA (10 mg) was suspended in 1 ml of 0.1 M sodium bicarbonate buffer (pH 9.5) and mixed with 1.73 mmol of peptide solution (5 mg/in 300 ml of water). The solution was mixed by end/over/end mixer overnight at room temperature. The DTPA-multi-lysine conjugate was purified with HPLC as described above and lyophilized. Lyophilized conjugate was dissolved in water (1 mg/ml) and stored at À201C.
Radiolabelling
The DTPA-multi-lys conjugate (120 mg) was mixed with 50 ml fresh solution of tin(II)chloride (10 mg/ml in 10 mM HCl) in a nitrogen atmosphere. 120 ml (120 MBq) of the 99m Tc-pertechnetate elution was added and incubated at room temperature for 10 min. After incubation the radiochemical purity was tested by using instant SPECT/CT imaging of baculovirus biodistribution in rat JK Räty et al thin-layer chromatography (ITLC) (SG, Pall Corporation, OEM Healthcare, MI, USA) in a 13 Â 1.5 cm strip and saline as the mobile phase.
Preparation of the viruses
The avidin-displaying baculovirus was constructed as described previously. 16 Briefly, a b-galactosidase (LacZ) cassette under a cytomegalovirus (CMV) promoter was cloned into a PvuII site of modified pFastBac1 donor vector (Invitrogen, Carlsbad, CA, USA), resulting in a BVlacZ-plasmid. Avidin-gp64 sequence under the control of the polyhedrin promoter was subcloned into the PstI site of a pBACSurf-1 vector (Novagen, Madison, WI, USA). The EcoRV/SnaBI fragment (2173 bp) containing the avidin-gp64 cassette was then cloned between the StuI sites of BvlacZ, resulting in Baavi donor plasmid.
All baculoviruses were generated by using the Bac-toBac (Invitrogen, CA, USA) method according to the manufacturer's instructions. Purification, concentration and titration of viral particles were performed as described earlier. 44 The avidin-displaying Baavi had an end point titer of 2.5 Â 10 10 PFU/ml and the wild-type virus was diluted to this concentration. Injected dose was 40 ml of virus with 300 mg labelled peptide in a volume of 300-400 ml with a radioactivity of 40-70 MBq, except in i.c.v. injections, where the total injected volume was 10 ml with an injected activity of 5-8 MBq. In chelate controls, the virus volume was replaced with the same volume of PBS.
Animal studies
Male Wistar rats (0.25-0.37 kg, National Laboratory Animal Center, Kuopio, Finland) were used for the experiments. The number of animals in each group was 2-5.
Intrafemoral preparation and injections
The animals were anesthetized with 2.0% isofluorane gas anesthesia with 30:70 oxygen/nitrogen, and the femoral region was shaven and purified with ethanol. The v. femoralis was prepared, a canyl was prepared from an intramedic Clay Adams Brand tube (Becton Dickinson Primary Care Diagnostics, Sparks, MD, USA) and a 30-gauge needle (BD Microlance, BD, Drogheda, Ireland) was inserted.
Stereotactic injections to rat cerebral ventricles
Rats were anesthetized intraperitoneally with a solution (0.150 ml/100 g) containing fentanyl-fluanisone (JanssenCilag, Hypnorm, Buckinghamshire, UK) and midazolame (Roche, Dormicum, Basel, Switzerland) and placed into stereotactic apparatus (Kopf Instruments, Tujunga, CA, USA). A total volume of 10 ml of the virus with radiolabelled chelate was injected by a Hamilton syringe and with a 27 gauge needle into the right lateral ventricle (coordinates: 1.0 mm caudal to bregma, 1.5 mm right to sutura sagittalis and into a depth of 3.5 mm).
In vivo SPECT/CT imaging
The animals were anesthetized by 1.5% isoflurane in N 2 / O 2 with ratios 70:30, respectively. The animals were fixed in prone position on the bed and centre of rotation relative to gantry of the dedicated small animal SPECT/ CT device (Gamma Medica, Northridge, CA, USA). Imaging was performed in two slightly overlapping sections. For planar gamma imaging a 120-240 s acquisition time with energy window 140 keV to À10 to +15% for 99m Tc and 710 keV for 111 In was used. 3D SPECT imaging was performed using 64 projections, 60 s/ projection with matrix size 81 Â 81 in 125 Â 125 mm 2 field-of-view (FOV). CT imaging was performed using the same coordinates as SPECT with 256 projections and 1024 Â 1024 projection matrix size and a voltage of 60 kV. Planar imaging was performed at the earliest possible time point after the injections (5-20 min) and alternating head to abdomen imaging at 5 min intervals. After 60 min of planar imaging, 3D SPECT was performed and the procedure was finished with CT imaging. The animals were imaged in two sections: (1) head and thorax and (2) abdomen.
Image reconstruction
SPECT 3D reconstruction was carried out using LumaGem program (Gamma Medica Northridge, CA, USA) using Butterworth sixth-order low-pass post-filtering with cutoff frequency 0.3. The same filter was used for planar gamma images. 3D CT images with dimensions of 512 Â 512 Â 512 matrix size in 87 Â 87 Â 87 mm 3 FOV were obtained. Both CT and SPECT images were interpolated into final 256 Â 256 Â 256 size matrices by using a vendor software (Gamma Medica Inc., Northridge, CA, USA).
Activity of the organs
The radioactivity of the dissected organs was measured by a Capintec CRC-120 (Capintec, Ramsey, NJ, USA) gammacounter and the results were equalized to the initial radioactivity, organ weight and administrated total dose.
Immunohistochemistry
Animals were killed with CO 2 after the last time point and perfused with 4% PFA+7.5% sucrose via transcardiac route or by 1 Â PBS for LacZ expression studies. After harvesting, the organs were frozen with solid carbon acid cooled isopentane (Sigma Aldrich, St Louis, MO, USA) and stored at À701C and a sample for RT-PCR was snap-frozen with liquid nitrogen and stored at À701C. Organs were cryosectioned and stained for b-galactosidase expression as described in Kaikkonen et al.
39
The immunostainings were performed as described previously, 7 but anti-b-galactosidase antibody (GeneTex, San Antonio, TX, USA) was used with 1:500 dilution.
RT-PCR
RT-PCR was performed as described earlier. 7 Briefly, the tissue sample was homogenized with a blade and Trizol (Invitrogen, Carlsbad, CA, USA). The RNA was extracted by phenol-chloroform method and cDNA was synthesized by using M-MuLV Reverse Transcriptase (Promega, Madison, WI, USA). Nested PCR was performed by using forward primers 5 0 -ttg gcc tag agt cga cgg and 5 0 -cca aga aga aac gca aag tg with respective reverse primers 5 0 -tga ggg gac gac gac agt at and 5 0 -cgc cat tcg cca ttc ag.
Statistical analysis
Prism 4 from GraphPad was used to analyse the results with analysis of variance and unpaired t-test to SPECT/CT imaging of baculovirus biodistribution in rat JK Räty et al determine whether the differences between subgroups were statistically significant.
